03/03/2026
If you think PCOS and menopause are only about hormones and insulin, we’re not deep enough yet.
At the cellular level, PCOS is a disorder of mitochondrial efficiency and intracellular signaling.
Long-standing hyperinsulinemia alters PI3 kinase signaling, reduces GLUT4 translocation, and pushes glucose storage toward visceral fat. Visceral fat then becomes hormonally active tissue, releasing inflammatory cytokines that worsen insulin resistance.
Now layer in menopause.
Loss of estradiol reduces mitochondrial biogenesis, impairs nitric oxide production, and decreases ATP efficiency. Fatigue increases. Central fat accumulates. Metabolic flexibility declines.
Add thyroid.
Thyroid hormone regulates mitochondrial transcription factors and basal metabolic rate. Even “normal” labs can mask impaired metabolic throughput in women with PCOS.
This is not separate systems.
It is one integrated metabolic circuit:
• Insulin resistance
• Ovarian androgen production
• Hepatic SHBG synthesis
• Thyroid signaling
• Cortisol rhythm
• Mitochondrial output
If you treat only one node, the network compensates.
If you treat the circuit, metabolism shifts.
That is what true PCOS-menopause management looks like.
This conversation is about cellular physiology not symptom chasing.